The notice, signed by Health Secretary Robert F. Kennedy Jr., said the move “does not mean that exposure to UV radiation does ...
Cancer treatment single injection results: A redesigned immunotherapy, injected directly into tumors, has shown remarkable ...
New data from the MEL-SELF trial show gaps in melanoma self-surveillance confidence, highlighting opportunities to improve early detection.
Restricting teens’ access to indoor tanning and informing the public about the dangers of indoor tanning are critical to preventing skin cancer,’ AAD President Susan C. Taylor, MD, said.
HealthDay on MSN
Women more likely to survive cancer than men — at a cost
Key Takeaways Women are more likely to survive cancer than menHowever, they also are more likely to develop severe side ...
Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially ...
We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...
Melanoma remains the most aggressive and lethal form of skin cancer, characterized by a high mutational burden and complex signaling dysregulation. Over the ...
Cancer remains one of the most serious health challenges in the world. It occurs when cells in the body begin to grow uncontrollably and form tumors that can spread to other organs. Although modern ...
Opinion
American Academy of Dermatology Association statement on FDA withdrawing proposed sunlamp regulation
The American Academy of Dermatology Association is disappointed that the Food and Drug Administration (FDA) is withdrawing its proposed rule on sunlamp regulation, which would have restricted ...
Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly or monthly despite >90% rating checks as important. Nearly half of trial ...
Announced Positive Data from Phase 1 Dose Expansion Study of varsetatug masetecan ("Varseta-M") EpCAM PROBODY(R) ADC in Patients with Advanced Colorectal Cancer (CRC) - - FDA interactions targeted for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results